EstechPharma Co. Ltd
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.
Market Cap & Net Worth: EstechPharma Co. Ltd (041910)
EstechPharma Co. Ltd (KQ:041910) has a market capitalization of $71.16 Million (₩104.19 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #20934 globally and #944 in its home market, demonstrating a 41.14% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EstechPharma Co. Ltd's stock price ₩8920.00 by its total outstanding shares 11680000 (11.68 Million).
EstechPharma Co. Ltd Market Cap History: 2015 to 2026
EstechPharma Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $174.32 Million to $71.16 Million (-8.32% CAGR).
Index Memberships
EstechPharma Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$166.01 Billion | 0.03% | #435 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$166.01 Billion | 0.03% | #435 of 1384 |
Weight: EstechPharma Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
EstechPharma Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EstechPharma Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
EstechPharma Co. Ltd's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
EstechPharma Co. Ltd's market cap is 0.01 times its annual earnings
0.19x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $174.32 Million | $45.07 Billion | -$870.03 Million | 0.00x | N/A |
| 2016 | $79.39 Million | $43.40 Billion | $4.15 Billion | 0.00x | 0.02x |
| 2017 | $91.33 Million | $38.21 Billion | $2.73 Billion | 0.00x | 0.03x |
| 2018 | $62.09 Million | $40.34 Billion | $6.59 Billion | 0.00x | 0.01x |
| 2019 | $79.50 Million | $46.49 Billion | $15.23 Billion | 0.00x | 0.01x |
| 2020 | $97.01 Million | $61.32 Billion | $10.96 Billion | 0.00x | 0.01x |
| 2021 | $74.42 Million | $60.40 Billion | $6.87 Billion | 0.00x | 0.01x |
| 2022 | $55.73 Million | $62.04 Billion | -$6.36 Billion | 0.00x | N/A |
| 2023 | $55.04 Million | $64.21 Billion | $3.82 Billion | 0.00x | 0.01x |
| 2024 | $42.76 Million | $59.60 Billion | $3.95 Billion | 0.00x | 0.01x |
Competitor Companies of 041910 by Market Capitalization
Companies near EstechPharma Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to EstechPharma Co. Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3469 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #5585 globally with a market cap of $1.61 Billion USD ( ₩2.36 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7048 globally with a market cap of $1.07 Billion USD ( ₩1.56 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7477 globally with a market cap of $962.14 Million USD ( ₩1.41 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3469 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩730000.00 |
| #5585 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.61 Billion | ₩113500.00 |
| #7048 | ST Pharm Co.Ltd | KQ:237690 | $1.07 Billion | ₩155100.00 |
| #7477 | Oscotec Inc | KQ:039200 | $962.14 Million | ₩59300.00 |
EstechPharma Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, EstechPharma Co. Ltd's market cap moved from $174.32 Million to $ 71.16 Million, with a yearly change of -8.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩71.16 Million | +43.18% |
| 2025 | ₩49.70 Million | +16.23% |
| 2024 | ₩42.76 Million | -22.32% |
| 2023 | ₩55.04 Million | -1.23% |
| 2022 | ₩55.73 Million | -25.12% |
| 2021 | ₩74.42 Million | -23.29% |
| 2020 | ₩97.01 Million | +22.03% |
| 2019 | ₩79.50 Million | +28.04% |
| 2018 | ₩62.09 Million | -32.02% |
| 2017 | ₩91.33 Million | +15.04% |
| 2016 | ₩79.39 Million | -54.46% |
| 2015 | ₩174.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of EstechPharma Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $71.16 Million USD |
| MoneyControl | $71.16 Million USD |
| MarketWatch | $71.16 Million USD |
| marketcap.company | $71.16 Million USD |
| Reuters | $71.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.